Journey Medical (DERM) Retained Earnings (2020 - 2025)
Journey Medical (DERM) has disclosed Retained Earnings for 6 consecutive years, with -$97.2 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Retained Earnings fell 9.78% year-over-year to -$97.2 million, compared with a TTM value of -$97.2 million through Sep 2025, down 9.78%, and an annual FY2024 reading of -$87.0 million, down 20.28% over the prior year.
- Retained Earnings was -$97.2 million for Q3 2025 at Journey Medical, down from -$94.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$17.1 million in Q3 2021 and bottomed at -$97.2 million in Q3 2025.
- Average Retained Earnings over 5 years is -$71.0 million, with a median of -$78.6 million recorded in 2023.
- The sharpest move saw Retained Earnings crashed 859.26% in 2021, then rose 0.97% in 2024.
- Year by year, Retained Earnings stood at -$38.9 million in 2021, then crashed by 76.22% to -$68.5 million in 2022, then fell by 5.62% to -$72.4 million in 2023, then dropped by 20.28% to -$87.0 million in 2024, then fell by 11.7% to -$97.2 million in 2025.
- Business Quant data shows Retained Earnings for DERM at -$97.2 million in Q3 2025, -$94.9 million in Q2 2025, and -$91.1 million in Q1 2025.